Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin

International Urology and Nephrology

Volumn 46, Issue 1, 2014, Pages 161-167

  Eleftheriadis, Theodoros ^a   Pissas, Georgios ^a   Remoundou, Maria ^a   Filippidis, Georgios ^a   Antoniadi, Georgia ^a   Oustampasidou, Niki ^a   Liakopoulos, Vassilios ^a   Stefanidis, Ioannis ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Erythropoietin; Ferroportin; Hemodialysis; Hepcidin; Inflammation; Iron

Indexed keywords

AGED; ANEMIA; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; DRUG RESISTANCE; ERYTHROPOIETIN; FEMALE; FERRITINS; HEMATINICS; HEMOGLOBINS; HEPCIDINS; HUMANS; INFLAMMATION; INTERLEUKIN-6; IRON; MALE; MIDDLE AGED; MONOCYTES; POLYETHYLENE GLYCOLS; RENAL DIALYSIS;

EID: 84893836781     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0497-9     Document Type: Article

References (23)

1. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR et al (1989) Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 111(12):992-1000 (Pubitemid 20034923)
2. Kanbay M, Perazella MA, Kasapoglu B, Koroglu M, Covic A (2010) Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and management. Blood Purif 29(1):1-12. doi: 10.1159/000245041
3. Kalantar-Zadeh K, Streja E, Miller JE, Nissenson AR (2009) Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia? Adv Chronic Kidney Dis 16(2):143-151. doi: 10.1053/j.ackd.2008.12.008
4. Rostoker G, Griuncelli M, Loridon C, Couprie R, Benmaadi A, Bounhiol C, Roy M, Machado G, Janklewicz P, Drahi G, Dahan H, Cohen Y (2012) Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study. Am J Med 125 (10):991-999 e991. doi: 10.1016/j.amjmed.2012. 01.015
5. Yamamoto H, Tsubakihara Y (2011) Limiting iron supplementation for anemia in dialysis patients-the Basis for Japan's conservative guidelines. Semin Dial 24(3):269-271. doi: 10.1111/j.1525-139X.2011.00938.x
6. Eleftheriadis T, Liakopoulos V, Antoniadi G, Kartsios C, Stefanidis I (2009) The role of hepcidin in iron homeostasis and anemia in hemodialysis patients. Semin Dial 22(1):70-77. doi: 10.1111/j.1525-139X.2008.00532.x
7. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704):2090-2093. doi: 10.1126/science.1104742 (Pubitemid 40007660)
8. Ganz T, Nemeth E (2012) Hepcidin and iron homeostasis. Biochim Biophys Acta 1823(9):1434-1443. doi: 10.1016/j.bbamcr.2012.01.014
9. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101(7):2461-2463. doi: 10.1182/blood-2002-10-3235 (Pubitemid 36857598)
10. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, Vaulont S (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99(7):4596-4601. doi: 10.1073/pnas.072632499 (Pubitemid 34286030)
11. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98(15):8780-8785. doi: 10.1073/pnas.151179498 (Pubitemid 32678104)
12. Eleftheriadis T, Kartsios C, Liakopoulos V, Antoniadi G, Ditsa M, Papadopoulos C, Anifandis G, Skirta A, Markala D, Stefanidis I (2006) Does hepcidin affect erythropoiesis in hemodialysis patients? Acta Haematol 116(4):238-244. doi: 10.1159/000095873 (Pubitemid 44795902)
13. Ford BA, Eby CS, Scott MG, Coyne DW (2010) Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients. Kidney Int 78(8):769-773. doi: 10.1038/ki.2010.254
14. Tessitore N, Girelli D, Campostrini N, Bedogna V, Pietro Solero G, Castagna A, Melilli E, Mantovani W, De Matteis G, Olivieri O, Poli A, Lupo A (2010) Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents. Nephrol Dial Transplant 25(12):3996-4002. doi: 10.1093/ndt/gfq321
15. van der Weerd NC, Grooteman MP, Bots ML, van den Dorpel MA, den Hoedt CH, Mazairac AH, Nube MJ, Penne EL, Gaillard CA, Wetzels JF, Wiegerinck ET, Swinkels DW, Blankestijn PJ, Ter Wee PM (2012) Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents. PLoS ONE 7(7):e39783. doi: 10.1371/journal.pone.0039783
16. Ward DM (1823) Kaplan J (2012) Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta 9:1426-1433. doi: 10.1016/j.bbamcr.2012.03.004
17. Erceg-Hurn DM, Mirosevich VM (2008) Modern robust statistical methods: an easy way to maximize the accuracy and power of your research. Am Psychol 63(7):591-601. doi: 10.1037/0003-066X.63.7.591
18. Andrews NC (1999) Disorders of iron metabolism. N Engl J Med 341(26):1986-1995. doi: 10.1056/NEJM199912233412607 (Pubitemid 30010408)
19. Coyne DW (2011) Hepcidin: clinical utility as a diagnostic tool and therapeutic target. Kidney Int 80(3):240-244. doi: 10.1038/ki.2011.141
20. Peters HP, Rumjon A, Bansal SS, Laarakkers CM, van den Brand JA, Sarafidis P, Musto R, Malyszko J, Swinkels DW, Wetzels JF, Macdougall IC (2012) Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA. Nephrol Dial Transplant 27(10):3923-3929. doi: 10.1093/ndt/gfs164
21. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I (2007) Disturbances of acquired immunity in hemodialysis patients. Semin Dial 20(5):440-451. doi: 10.1111/j.1525-139X.2007.00283.x
22. Torti FM, Torti SV (2002) Regulation of ferritin genes and protein. Blood 99(10):3505-3516 (Pubitemid 34534516)
23. Wish JB (2006) Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 1(Suppl 1):S4-S8. doi: 10.2215/CJN.01490506